Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
US Wholesaler Files Class Action Against Novo Nordisk Over Diabetes Drug Victoza Monopoly Claims sheeba farhat27 Jan 2026 2:47 PM ISTSmith Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers.
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030 sheeba farhat13 Jan 2026 5:23 PM ISTNovo launched a daily oral version of Wegovy in the U.S. earlier this month with a starting cash price of USD 149 per month.
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts sheeba farhat9 Jan 2026 11:28 PM ISTBengaluru: Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic,...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle sheeba farhat7 Jan 2026 4:04 PM ISTCEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company issued multiple profit...
Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market sheeba farhat5 Jan 2026 6:19 PM ISTThe Wegovy pill could attract new consumers as Novo looks to revive its fortunes after profit warnings and sliding shares in 2025.
Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro Ruchika Sharma30 Dec 2025 6:08 PM ISTGlobal drugmakers Novo Nordisk and Eli Lilly have kicked off a price battle in China’s obesity treatment market, cutting prices of their blockbuster...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
